These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8269105)

  • 1. In response to: Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies.
    Huysmans H
    J Heart Valve Dis; 1993 Jan; 2(1):122-3. PubMed ID: 8269105
    [No Abstract]   [Full Text] [Related]  

  • 2. In response to: Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies.
    Turina M
    J Heart Valve Dis; 1993 Jan; 2(1):123. PubMed ID: 8269106
    [No Abstract]   [Full Text] [Related]  

  • 3. In response to: Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies.
    Blackstone EH
    J Heart Valve Dis; 1993 Jan; 2(1):119-22. PubMed ID: 8269104
    [No Abstract]   [Full Text] [Related]  

  • 4. In response to: Grunkemeier GL, Starr A. Alternatives to randomization in surgical studies.
    Wheatley DJ
    J Heart Valve Dis; 1993 Mar; 2(2):248. PubMed ID: 8261164
    [No Abstract]   [Full Text] [Related]  

  • 5. Will randomized trials detect random valve failure? Reflections on a recent FDA workshop.
    Grunkemeier GL
    J Heart Valve Dis; 1993 Jul; 2(4):424-9. PubMed ID: 8269145
    [No Abstract]   [Full Text] [Related]  

  • 6. Alternatives to randomization in surgical studies.
    Grunkemeier GL; Starr A
    J Heart Valve Dis; 1992 Nov; 1(2):142-51. PubMed ID: 1341621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation and analysis of heart valve substitutes.
    Grunkemeier GL; Anderson WN
    J Heart Valve Dis; 1998 Mar; 7(2):163-9. PubMed ID: 9587856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 9. Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial.
    Grunkemeier GL; Jin R; Starr A
    Ann Thorac Surg; 2006 Sep; 82(3):776-80. PubMed ID: 16928482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronicle of a defective heart valve prosthesis].
    van der Graaf Y; Kallewaard M; Algra A
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1645-8. PubMed ID: 9763854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible barriers for the availability of devices for patients with congenital heart disease and potential solutions.
    Hijazi ZM
    Catheter Cardiovasc Interv; 2005 Feb; 64(2):257-8. PubMed ID: 15678445
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential conflict between fundamental ethical principles and requirements of the oncology drug approval process: ethical conflict in drug approval.
    Markman M; DeMarco J
    Cancer; 2003 Jul; 98(2):215-8. PubMed ID: 12872337
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to correspondence on randomization in surgical studies.
    Grunkemeier GL; Starr A
    J Heart Valve Dis; 1993 May; 2(3):359-61. PubMed ID: 8269134
    [No Abstract]   [Full Text] [Related]  

  • 14. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective.
    Sapirstein W
    Am Heart J; 2001 May; 141(5):861-3. PubMed ID: 11320379
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory, bioengineering and clinical requirements for cardiac valves: a new approach for a unique market.
    Lespinasse F; Grimaud E; Piwnica A
    J Heart Valve Dis; 1994 Sep; 3(5):461-7. PubMed ID: 8000576
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to Food and Drug Administration draft guidance statement on research into the treatment of life-threatening emergency conditions using exception from informed consent: testimony of the Resuscitation Outcomes Consortium.
    Ornato JP
    Acad Emerg Med; 2007 Apr; 14(4):e45-9. PubMed ID: 17400994
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

  • 20. An oncoethical issue.
    Cheson BD
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):241. PubMed ID: 16779896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.